Subodh Kumar – författare

Stem Cells: An Alternative Therapy for COVID-19 and Cytokine Storm provides mechanistic insights into the role of stem cells to combat COVID-19 outbreak and other pathologies where cytokines storm is the cause of concern for e.g., radiation exposure, multiple organ failure and sepsis. There has been an increase in number of cases of new diseases in the last decade, including mucormycosis, Zika virus, H1N1 influenza virus, among others. These diseases can be characterized by the induction of cytokine storm, which is mainly responsible for morbidity and mortality.Stem cell therapy has emerged as a potential treatment for viral diseases, including, but not limited to, COVID-19. Interestingly, clinical trials in patients with COVID-19 complications depicted faster recovery in patients post mesenchymal stem cells therapy owing to the decreased cytokines levels, anti-viral effects and regeneration of the infected tissue. Evaluates the role of MSCs to combat cytokine storm, the challenges regarding COVID-19 therapy and how they can be countered using stem cells, and the risk of opportunistic infections post COVID-19 Presents how stem cell therapy has emerged as a potential treatment for viral diseases, including, but not limited to, COVID-19 Provides a detailed understanding of the novel coronavirus, with an emphasis on therapeutic aspects

Fundamentals of Translational Tissue Engineering explores the practical dimensions of tissue engineering (TE), outlining the intricate path of development of tissue engineered products. The book navigates the reader through the fundamental aspects and challenges in TE, equipping the reader with insights crucial to comprehending the journey a tissue engineered product traverses on its way to clinical translation. The first section, Material Sciences, provides the reader with a general overview covering the basics of scaffolds, biomaterials and techniques, while the larger, second section, Biological and Clinical Aspects, discussing the biological perspectives relating to tissue engineering.This is a multi-disciplinary work that will be ideal for audiences of varying levels of expertise, from the novice exploring fundamental concepts or the seasoned professionals seeking comprehensive information, readers of all backgrounds will be able to access and benefit from this tailored approach.Provides a fundamental understanding of tissue engineering, covering challenges, limitations, and industry perspectivesOffers insights into the clinical translation of biomedical products, aiding both novice and experienced researchers in understanding the journey from bench to bedsideAddresses social issues related to organ donation, providing a platform for ethical discussions

In modern computer science, there exists no truly sequential computing system; and most advanced programming is parallel programming. This is particularly evident in modern application domains like scientific computation, data science, machine intelligence, etc. This lucid introductory textbook will be invaluable to students of computer science and technology, acting as a self-contained primer to parallel programming. It takes the reader from introduction to expertise, addressing a broad gamut of issues. It covers different parallel programming styles, describes parallel architecture, includes parallel programming frameworks and techniques, presents algorithmic and analysis techniques and discusses parallel design and performance issues. With its broad coverage, the book can be useful in a wide range of courses; and can also prove useful as a ready reckoner for professionals in the field.

Viral Oncology: New Approaches to Molecular Cancer Therapeutics offers a comprehensive exploration of how viruses contribute to cancer development, bridging the gap between basic virology and clinical oncology. Featuring contributions from leading researchers, this authoritative text examines the mechanisms of viral oncogenesis, key oncogenic viruses, and the latest therapeutic strategies. The book highlights cutting-edge research on Human Papillomavirus (HPV), Epstein-Barr Virus (EBV), Hepatitis B and C, and other cancer-causing viruses, providing clinicians and researchers with critical insights into the prevention, diagnosis, and treatment of virus-induced cancers. Ideal for oncologists, virologists, and molecular biologists, this text equips readers with both foundational knowledge and the latest advancements in the rapidly evolving field of viral oncology. Stay ahead in the field with this definitive guide to understanding and combating virusinduced malignancies. The volume explores the biology and pathology of oncogenic viruses, offering insights into novel therapeutic approaches, including immunotherapy and gene editing. Viral Oncology: New Approaches to Molecular Cancer Therapeutics presents an in-depth and authoritative examination of how oncogenic viruses contribute to cancer development and progression, bridging the critical gap between foundational virology and clinical oncology. This volume brings together groundbreaking research from world-renowned scientists and clinicians who explore the complex mechanisms of viral oncogenesis, shedding light on both well-established and emerging viral agents, such as HPV, EBV, Hepatitis B and C, and Kaposi’s Sarcoma-associated Herpesvirus (KSHV). The text delves into the molecular processes through which these viruses initiate and sustain cancerous growth, offering insights into viral integration, immune evasion, and cellular transformation. With a focus on the latest developments in therapeutic strategies, Viral Oncology covers innovative approaches, including targeted molecular therapies, immunotherapies, gene editing techniques, and personalized medicine strategies aimed at halting virus-induced tumorigenesis. Designed for a broad audience of oncologists, virologists, molecular biologists, and clinical researchers, this text provides a thorough understanding of the epidemiology, pathology, and treatment implications of viral oncology. It serves as an indispensable guide to the mechanisms of virus-driven cancers and how these insights are being translated into cutting-edge therapeutic interventions. With its rich blend of cutting-edge science, clinical applications, and visionary outlook, Viral Oncology: New Approaches to Molecular Cancer Therapeutics is an essential resource for any professional involved in cancer research, diagnostics, and treatment. Whether you are a seasoned oncologist, virologist, or a researcher investigating the molecular basis of cancer, this book offers the latest knowledge and tools to effectively understand and combat virus-induced malignancies. Stay at the forefront of the rapidly evolving field of viral oncology with this comprehensive and forward-looking text – a definitive resource for understanding the interplay between viruses and cancer, and harnessing that knowledge for therapeutic innovation.

Viral Oncology: New Approaches to Molecular Cancer Therapeutics offers a comprehensive exploration of how viruses contribute to cancer development, bridging the gap between basic virology and clinical oncology. Featuring contributions from leading researchers, this authoritative text examines the mechanisms of viral oncogenesis, key oncogenic viruses, and the latest therapeutic strategies. The book highlights cutting-edge research on Human Papillomavirus (HPV), Epstein-Barr Virus (EBV), Hepatitis B and C, and other cancer-causing viruses, providing clinicians and researchers with critical insights into the prevention, diagnosis, and treatment of virus-induced cancers. Ideal for oncologists, virologists, and molecular biologists, this text equips readers with both foundational knowledge and the latest advancements in the rapidly evolving field of viral oncology. Stay ahead in the field with this definitive guide to understanding and combating virusinduced malignancies. The volume explores the biology and pathology of oncogenic viruses, offering insights into novel therapeutic approaches, including immunotherapy and gene editing. Viral Oncology: New Approaches to Molecular Cancer Therapeutics presents an in-depth and authoritative examination of how oncogenic viruses contribute to cancer development and progression, bridging the critical gap between foundational virology and clinical oncology. This volume brings together groundbreaking research from world-renowned scientists and clinicians who explore the complex mechanisms of viral oncogenesis, shedding light on both well-established and emerging viral agents, such as HPV, EBV, Hepatitis B and C, and Kaposi’s Sarcoma-associated Herpesvirus (KSHV). The text delves into the molecular processes through which these viruses initiate and sustain cancerous growth, offering insights into viral integration, immune evasion, and cellular transformation. With a focus on the latest developments in therapeutic strategies, Viral Oncology covers innovative approaches, including targeted molecular therapies, immunotherapies, gene editing techniques, and personalized medicine strategies aimed at halting virus-induced tumorigenesis. Designed for a broad audience of oncologists, virologists, molecular biologists, and clinical researchers, this text provides a thorough understanding of the epidemiology, pathology, and treatment implications of viral oncology. It serves as an indispensable guide to the mechanisms of virus-driven cancers and how these insights are being translated into cutting-edge therapeutic interventions. With its rich blend of cutting-edge science, clinical applications, and visionary outlook, Viral Oncology: New Approaches to Molecular Cancer Therapeutics is an essential resource for any professional involved in cancer research, diagnostics, and treatment. Whether you are a seasoned oncologist, virologist, or a researcher investigating the molecular basis of cancer, this book offers the latest knowledge and tools to effectively understand and combat virus-induced malignancies. Stay at the forefront of the rapidly evolving field of viral oncology with this comprehensive and forward-looking text – a definitive resource for understanding the interplay between viruses and cancer, and harnessing that knowledge for therapeutic innovation.